Statistics for Jazz Pharmaceuticals PLC (id:7253 JAZZ)
Valuation metrics
Market cap
7.41B
Enterprise value
11.01B
Trailing P/E (ttm)
17.37
Forward P/E
5.69
PEG ratio
5.69
Price/Sales (ttm)
1.86
Price/Book (mrq)
1.78
Enterprise Value/Revenue
2.76
Enterprise Value/EBITDA
7.25
Overview
Shares outstanding
60.45M
Float
58.67M
Shares short
4.25M
% Held by insiders
5.00%
% Held by institutions
3.00%
Average volume (10 days)
629.03K
Average volume (90 days)
Price summary
52-Week low
99.06
52-Week high
134.17
52-Week change
1.06%
Beta
3.00
50-Day moving average
118.31
200-Day moving average
112.69
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
11.60%
Operating margin
24.66%
Operational effectiveness
Return on assets
4.62%
Return on equity
12.09%
Income statement
Revenue (ttm)
64.04
Revenue per share (ttm)
64.04
Quarterly revenue growth (yoy)
3.00
Gross profit (ttm)
3.40B
EBITDA
1.33B
Net income to common (ttm)
463.16M
Diluted EPS (ttm)
7.06
Quarterly earnings growth (yoy)
46.50%
Balance sheet
Total cash (mrq)
2.62B
Total cash per share (mrq)
43.31
Total debt (mrq)
6.20B
Total Debt/Equity (mrq)
148.75
Current ratio (mrq)
426.30%
Book value per share (mrq)
69.01
Cash flow
Cash flow statement
1.16B
Levered free cash flow (LFCF)
1.05B